Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Myelodysplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03572764
What this trial is testing

CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00451048
What this trial is testing

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromesMyelodysplastic Syndromes+1 more
National Cancer Institute (NCI) 10
Early research (Phase 1)Ended earlyNCT01003678
What this trial is testing

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

Who this might be right for
Myelodysplastic Syndrome
Roswell Park Cancer Institute 4
Testing effectiveness (Phase 2)Looking for participantsNCT07046078
What this trial is testing

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Who this might be right for
Acute Leukemia of Ambiguous LineageAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01246076
What this trial is testing

Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Who this might be right for
Myelodysplastic Syndromes
Washington University School of Medicine 24
Early research (Phase 1)Study completedNCT00840931
What this trial is testing

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)Study completedNCT02264873
What this trial is testing

Phase I, Dose Escalation Study of Decitabine

Who this might be right for
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
University of Florida 3
Testing effectiveness (Phase 2)Study completedNCT00067028
What this trial is testing

Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myeloid Leukemia
M.D. Anderson Cancer Center 116
Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00322101
What this trial is testing

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Acute Myeloid Leukemia in Remission+16 more
Fred Hutchinson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01289457
What this trial is testing

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 282
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04097470
What this trial is testing

Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients

Who this might be right for
AML/MDS
Stichting Hemato-Oncologie voor Volwassenen Nederland 140
Large-scale testing (Phase 3)Ended earlyNCT00038805
What this trial is testing

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01249820
What this trial is testing

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Who this might be right for
LeukemiaMyelodysplastic SyndromeLeukemia, Myeloid, Acute
Radboud University Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT01980056
What this trial is testing

Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy

Who this might be right for
Myelodysplastic Syndrome
Weill Medical College of Cornell University 10
Early research (Phase 1)Study completedNCT03359460
What this trial is testing

Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromePreviously Treated Myelodysplastic SyndromeRefractory High Risk Myelodysplastic Syndrome+2 more
University of California, Davis 4
Early research (Phase 1)Looking for participantsNCT04375631
What this trial is testing

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
Fred Hutchinson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00516828
What this trial is testing

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
NCIC Clinical Trials Group 21
Large-scale testing (Phase 3)Looking for participantsNCT04708054
What this trial is testing

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 324
Next Page
20
79